DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS

Synopsis of Open Program Funding Opportunities


FY21 Alcohol and Substance Abuse Disorders Research Program (ASADRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Consortium Award Program Announcement
Application Instructions
June 16, 2021
  • The maximum period of performance is 5 years.
  • The CDMRP expects to allocate FY21-23 funding, if appropriated, to fund approximately one ASADRP Consortium Award.
  • The ASADRP Consortium will be funded initially with allocations from the FY21 ASADRP congressional appropriation ($3.525M).
  • The maximum allowable total costs (direct and indirect) for the entire period of performance are $10.575M (initial period of performance plus 2 options).
  • Two additional options, to be included in the application, may be funded from allocations from the FY22 and FY23 congressional appropriation (up to $3.525M each year) subject to Programmatic Panel review, approval of the Grants Officer, and receipt of future congressional appropriations.
Pre-Application (Letter of Intent):
August 18, 2021

Application:
September 8, 2021

FY21 Breast Cancer Research Program (BCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Breakthrough Award Levels 1 and 2 II Program Announcement
Application Instructions
April 26, 2021 Funding Level 1:
  • Maximum funding of $450,000 for direct costs (plus indirect costs).
  • The maximum period of performance is years.

Funding Level 1 with Partnering PI Option:

  • Maximum funding of $750,000 for direct costs (plus indirect costs).
  • The maximum period of performance is years.

Funding Level 2:

  • Maximum funding of $1 million (M) for direct costs (plus indirect costs).
  • The maximum period of performance is years.

Funding Level 2 – Population Science and Prevention Studies:

  • Maximum funding of $1.5M for direct costs (plus indirect costs).
  • The maximum period of performance is years.

Funding Level 2 with Partnering PI Option:

  • Maximum funding of $1.5M for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.

Funding Level 2 – Population Science and Prevention Studies – Partnering PI Option:

  • Maximum funding of $2M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
Pre-Application (Letter of Intent): August 31, 2021

Application: September 14, 2021
Era of Hope Scholar Award II Program Announcement
Application Instructions
April 26, 2021
  • Maximum funding of $3M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
Pre-Application (Letter of Intent): August 31, 2021

Application: September 14, 2021

Confidential Letters of Recommendation Submission Deadline: September 17, 2021


FY21 Combat Readiness – Medical Research Program (CRRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Rapid Development and Translational Research Award Extramural applicants:
Broad Agency Announcement
General Submission Instructions

Intramural applicants:
Program Announcement Announcement
July 16, 2021 RDTRA:
  • Maximum funding of $1,800,000 for total costs (to include direct and indirect costs).
  • Maximum period of performance is 2 years.
RDTRA with Option:
  • Maximum funding of $1,800,000 (RDTRA) and 1,000,000 (Option) for total costs (to include direct and indirect costs).
  • Maximum period of performance is 2 years for the RDTRA base award and 1 year for the Option.
Pre-Application (Preproposal):
August 31, 2021

Proposal/Application:
December 1, 2021


DMDRP

FY21 Duchenne Muscular Dystrophy Research Program (DMDRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Idea Development Award Program Announcement
Application Instructions
May 27, 2021
  • Maximum funding of $350,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.
Pre-Application:
August 11, 2021

Preproposal is required; application submission is by invitation only.

Application:
December 1, 2021
Translational Research Award Program Announcement
Application Instructions
May 27, 2021
  • Maximum funding of $1,300,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
Pre-Application:
August 11, 2021

Preproposal is required; application submission is by invitation only.

Application:
December 1, 2021


FY21 Kidney Cancer Research Program (KCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Academy of Kidney Cancer Investigators – Early-Career Investigator Award Program Announcement
Application Instructions
June 14, 2021
  • Maximum funding of $725,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
Pre-Application (Letter of Intent):
September 14, 2021

Application:
October 5, 2021
Clinical Research Nurse Development Award Program Announcement
Application Instructions
June 14, 2021
  • Maximum funding of $300,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
Pre-Application (Letter of Intent):
September 14, 2021

Application:
October 5, 2021
Clinical Trial Award Program Announcement
Application Instructions
June 14, 2021
  • Maximum funding of $2,000,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
Pre-Application (Letter of Intent):
September 14, 2021

Application:
October 5, 2021


LRP

FY21 Lupus Research Program (LRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Idea Award Program Announcement
Application Instructions
April 26, 2021
  • The maximum allowable funding for the entire period of performance is $300,000 in total costs (direct plus indirect costs).
  • The maximum period of performance is 2 years.
Pre-Application (Letter of Intent): August 24, 2021

Application: September 22, 2021
Impact Award Program Announcement
Application Instructions
April 26, 2021
  • The maximum allowable funding for the entire period of performance is $750,000 in total costs (direct plus indirect costs).
  • The maximum period of performance is 4 years.
Pre-Application (Letter of Intent): August 24, 2021

Application: September 22, 2021
Transformative Vision Award Program Announcement
Application Instructions
April 26, 2021
  • The maximum allowable funding for the entire period of performance is $2,500,000 in total costs (direct plus indirect costs).
  • The maximum period of performance is 4 years.
Pre-Application (Letter of Intent): August 24, 2021

Application: September 22, 2021


FY21 Melanoma Research Program (MRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Melanoma Academy Leadership Award Program Announcement
Application Instructions
May 7, 2021
  • The maximum allowable funding for the entire period of performance is $1,300,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
Pre-Application (Letter of Intent):
August 4, 2021

Application:
August 26, 2021
Melanoma Academy Scholar Award Program Announcement
Application Instructions
May 7, 2021
  • The maximum allowable funding for the entire period of performance is $500,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
Pre-Application (Letter of Intent):
August 4, 2021

Application:
August 26, 2021
Mid-Career Accelerator Award Program Announcement
Application Instructions
May 7, 2021
  • The maximum allowable funding for the entire period of performance is $750,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
Pre-Application (Letter of Intent):
September 9, 2021

Application:
September 28, 2021
Team Science Award Program Announcement
Application Instructions
May 7, 2021
  • The maximum allowable funding for the entire period of performance is $700,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
Pre-Application (Letter of Intent):
September 9, 2021

Application:
September 28, 2021
Translational Research Award Program Announcement
Application Instructions
May 7, 2021
  • The maximum allowable funding for the entire period of performance is $600,000 for direct costs.
  • Collaboration Option: The maximum allowable funding for the entire period of performance is $700,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
Pre-Application (Letter of Intent):
September 9, 2021

Application:
September 28, 2021
MSRP

FY21 Multiple Sclerosis Research Program (MSRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Early Investigator Research Award Program Announcement
Application Instructions
May 10, 2021
  • Maximum funding of $200,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.
Pre-Application (Letter of Intent): September 7, 2021
Application: October 1, 2021


FY21 Neurotoxin Exposure Treatment Parkinson’s Research Program (NETP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Early Investigator Research Award Program Announcement
Application Instructions
May 27, 2021
  • Maximum funding of $400,000 for total costs (includes direct and indirect costs).
  • Maximum period of performance is 2 years.
Pre-Application (Letter of Intent):
Septemeber 8, 2021

Application:
September 29, 2021
Investigator-Initiated Research Award Program Announcement
Application Instructions
May 27, 2021
  • Maximum funding of $1.2 million (M) for total costs (includes direct and indirect costs).
  • Maximum Period of performance is 3 years.
Pre-Application (Letter of Intent):
Septemeber 8, 2021

Application:
September 29, 2021
Synergistic Idea Award Program Announcement
Application Instructions
May 27, 2021
  • Maximum funding of $3 million (M) for total costs (includes direct and indirect costs).
  • Maximum Period of performance is 4 years.
Pre-Application (Letter of Intent):
Septemeber 8, 2021

Application:
September 29, 2021




FY21 Prostate Cancer Research Program (PCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Idea Development Award Program Announcement
Application Instructions
April 5, 2021
  • The maximum allowable funding for the entire period of performance is $750,000 for direct costs.
  • The maximum period of performance is 3 years.
Pre-application (Letter of Intent): September 2, 2021

Application: September 23, 2021
Clinical Consortium Award Program Announcement
Application Instructions
April 8, 2021 Coordinating Center:
  • Maximum funding of $7,200,000 for direct costs (plus indirect costs), including no less than $500,000 per year for support of two or more Affiliate Clinical Research Sites.
  • Maximum period of performance is 4 years.

Clinical Sites:

  • Maximum funding of $1,200,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years
Pre-Application (Letter of Intent): September 2, 2021

Application: September 23, 2021

FY21 Scleroderma Research Program (SRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Idea Development Award Program Announcement
Application Instructions
May 14, 2021 The maximum allowable funding for the entire period of performance is $300,000 for direct costs.

New Investigator Collaboration Option:

  • The maximum allowable funding for the entire period of performance is $450,000 for direct costs.
  • At least fifty percent of the funding must be allocated to the new investigator.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
Pre-Application (Letter of Intent): August 11, 2021

Application:
August 25, 2021
Translational Research Partnership Award Program Announcement
Application Instructions
May 14, 2021
  • The maximum period of performance is years.
  • The maximum allowable funding for the entire period of performance is $750,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
Pre-Application (Letter of Intent): August 11, 2021

Application:
August 25, 2021




Last updated Sunday, August 1, 2021